Skip to Content

MYLAN 5375 MYLAN 5375 (Doxepin 75 mg)

Pill imprint MYLAN 5375 MYLAN 5375 has been identified as Doxepin hydrochloride 75 mg.

Doxepin is used in the treatment of insomnia; anxiety; urticaria; reflex sympathetic dystrophy syndrome; major depressive disorder (and more), and belongs to the drug classes miscellaneous anxiolytics, sedatives and hypnotics, tricyclic antidepressants. FDA has not classified the drug for risk during pregnancy. Doxepin 75 mg is not a controlled substance under the Controlled Substance Act (CSA).

Doxepin hydrochloride 75 mg MYLAN 5375 MYLAN 5375
Doxepin hydrochloride 75 mg MYLAN 5375 MYLAN 5375
Doxepin hydrochloride 75 mg MYLAN 5375 MYLAN 5375
Doxepin hydrochloride
MYLAN 5375 MYLAN 5375
75 mg
18.00 mm
Prescription only
Drug Class:
Miscellaneous anxiolytics, sedatives and hypnotics
Tricyclic antidepressants
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
D&C Yellow No. 10
titanium dioxide
FD&C Green No. 3
ferrosoferric oxide
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
propylene glycol
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0645 UDL Laboratories Inc
58016-0797 Southwood Pharmaceuticals Inc (repackager)
16590-0485 Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.